Axiom Health Announces Key Leadership Appointments to Boost Market Presence and Client Value

On March 28, 2024, Axiom Health announced two key appointments to enhance their leadership capabilities and support the company’s efforts to expand its market presence and deliver increased value to clients. Russell “Rusty” Lewis was named Chief Executive Officer (CEO) and Jim Best was appointed Chief Commercial Officer (CCO).

Russell Lewis, with his extensive healthcare leadership experience, will bring valuable insights to his role as CEO. He has held key positions in organizations like McKesson, Amerisource Bergen, and Vizient, where he focused on driving innovation in healthcare technology. His expertise will be crucial in guiding Axiom Health’s growth trajectory.

Jim Best, the new CCO, joins Axiom Health with over 20 years of experience in the healthcare industry. He has held sales and marketing leadership positions at companies like Stryker, Integra Lifesciences, TriMed, and Komodo Health. His deep understanding of the challenges faced by medical device sales and marketing teams will be valuable in enhancing client success initiatives at Axiom Health.

Axiom Health is dedicated to empowering sales and marketing teams in the medical device industry with data-driven insights that drive informed decision-making and lead to better outcomes. The company’s analytics platform provides in-depth data that helps organizations optimize their strategies and stimulate growth. With these new appointments on board, the company is confident that they will support their commitment to delivering exceptional value in the medical device market.

For more information about Axiom Health or their new leadership team members please contact the Media Relations Department at [email protected] or visit their website at www.axiomhealth.com